Expression time |
Embryonic stage |
Embryonic stage |
Start to increase in the perinatal period and becomes predominant in the adulthood |
High in Embryonic heart tissue and then decrease and disappear in adult heart |
Cardiac tissues expression |
SAN, AVN, atria, PF networks, Ventricles |
SAN, AVN, atria, PF networks, poorly or not expressed in ventricular |
SAN, AVN, atria, PF networks, poorly or not expressed in ventricular tissue |
SAN, AVN, atria, PF networks, poorly expressed in ventricular tissue |
Voltage dependent activation |
High threshold of activation (~−40 mV) Fast activation |
Lower threshold of activation than Cav1.2 (~−55 mV) Fast activation |
Lower threshold of activation (~−70 mV) Slow activation |
|
Inactivation properties |
Ca2+ and voltage dependent inactivation |
Ca2+ and voltage dependent inactivation |
Fast voltage dependent inactivation |
|
DHP sensitivity |
High |
Lower than Cav1.2 |
Low and very low |
|
Role in pacemaking |
Control the Ca2+ dependent upstroke phase of action potential |
Diastolic pacemaker current |
Diastolic pacemaker current |
|
Knock-out mice phenotype |
Lethal |
Strong bradycardia, SAN arrhythmia, conduction system dysfunction |
Mild bradycardia AV conduction disorders |
No phenotype |